Terms: = Sarcomas AND PDGFB, SIS, 5155, ENSG00000100311, FLJ12858, PDGF2, P01127, c-sis, SSV AND Prognosis
21 results:
1. Establishment and characterization of NCC-DFSP5-C1: a novel patient-derived dermatofibrosarcoma protuberans cell line.
Ono T; Noguchi R; Osaki J; Akiyama T; Adachi Y; Kojima N; Toda Y; Fukushima S; Yoshimatsu Y; Yoshida A; Kawai A; Kondo T
Hum Cell; 2024 May; 37(3):854-864. PubMed ID: 38372888
[TBL] [Abstract] [Full Text] [Related]
2. COL1A1::pdgfb fusion-associated uterine fibrosarcoma: A case report and review of the literature.
Rota S; Franza A; Fabbroni C; Paolini B; Greco FG; Alessi A; Padovano B; Casali P; Sanfilippo R
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1969. PubMed ID: 38279510
[TBL] [Abstract] [Full Text] [Related]
3. Mutation Profile via Next-Generation Sequencing in Patients with Colorectal Adenocarcinoma and Its Clinicopathological Correlation.
Osman S; Kahraman Çetin N; Erdoğdu İH; Meteoğlu İ
Turk J Gastroenterol; 2023 Nov; 34(11):1124-1133. PubMed ID: 37737217
[TBL] [Abstract] [Full Text] [Related]
4. COL1A1-pdgfb Fusion Associated Fibrosarcoma of the Uterine Corpus: A Case Report and Literature Review.
Panwar V; Liu Y; Gwin K; Chen H
Int J Gynecol Pathol; 2023 Mar; 42(2):143-146. PubMed ID: 36729934
[TBL] [Abstract] [Full Text] [Related]
5. Multi-omics analysis identifies osteosarcoma subtypes with distinct prognosis indicating stratified treatment.
Jiang Y; Wang J; Sun M; Zuo D; Wang H; Shen J; Jiang W; Mu H; Ma X; Yin F; Lin J; Wang C; Yu S; Jiang L; Lv G; Liu F; Xue L; Tian K; Wang G; Zhou Z; Lv Y; Wang Z; Zhang T; Xu J; Yang L; Zhao K; Sun W; Tang Y; Cai Z; Wang S; Hua Y
Nat Commun; 2022 Nov; 13(1):7207. PubMed ID: 36418292
[TBL] [Abstract] [Full Text] [Related]
6. Dermatofibrosarcoma protuberans of the face: A clinicopathologic and molecular study of 34 cases.
Han Q; Chen M; Yang J; Du T; Peng H
J Dtsch Dermatol Ges; 2022 Nov; 20(11):1463-1473. PubMed ID: 36377270
[TBL] [Abstract] [Full Text] [Related]
7. Successful treatment of metastatic fibrosarcomatous dermatofibrosarcoma protuberans with imatinib mesylate.
Kambayashi Y; Kasahara Y; Ohuchi K; Amagai R; Hashimoto A; Asano Y; Fujimura T
Dermatol Ther; 2022 Oct; 35(10):e15736. PubMed ID: 35898161
[TBL] [Abstract] [Full Text] [Related]
8. [Clinicopathological characteristics and molecular alterations of primary cardiac leiomyosarcoma: report of five cases].
Dong F; Chen D; Shang JF; Fang W; Han LY; Lian GL; Wang H; Zheng MH
Zhonghua Bing Li Xue Za Zhi; 2022 Jun; 51(6):512-517. PubMed ID: 35673722
[No Abstract] [Full Text] [Related]
9. Expression and prognostic significance of PDGF ligands and receptors across soft tissue sarcomas.
Brahmi M; Lesluyes T; Dufresne A; Toulmonde M; Italiano A; Mir O; Le Cesne A; Valentin T; Chevreau C; Bonvalot S; Penel N; Coindre JM; Le Guellec S; Le Loarer F; Karanian M; Blay JY; Chibon F
ESMO Open; 2021 Feb; 6(1):100037. PubMed ID: 33524869
[TBL] [Abstract] [Full Text] [Related]
10. Dermatofibrosarcoma protuberans, fibrosarcomatous variant: A rare tumor in children.
Chicaud M; Frassati-Biaggi A; Kaltenbach S; Karanian M; Orbach D; Fraitag S
Pediatr Dermatol; 2021 Jan; 38(1):217-222. PubMed ID: 33010051
[TBL] [Abstract] [Full Text] [Related]
11. Pigmented Dermatofibrosarcoma Protuberans: Description of a pediatric case.
Nieto-Benito LM; Berenguer-Fröhner B; Parra-Blanco V; Campos-Domínguez M
Rev Chil Pediatr; 2020 Feb; 91(1):99-104. PubMed ID: 32730419
[TBL] [Abstract] [Full Text] [Related]
12. Dermatofibrosarcoma protuberans with fibrosarcomatous transformation: a case report.
Hrudka J; Charvát M; Grossmann P; Kinkor Z
Cesk Patol; 2020; 56(2):89-93. PubMed ID: 32493025
[TBL] [Abstract] [Full Text] [Related]
13. Establishment and characterization of NCC-DFSP3-C1: a novel patient-derived dermatofibrosarcoma protuberans cell line.
Yoshimatsu Y; Noguchi R; Tsuchiya R; Sei A; Nakagawa M; Yoshida A; Kawai A; Kondo T
Hum Cell; 2020 Jul; 33(3):894-903. PubMed ID: 32356243
[TBL] [Abstract] [Full Text] [Related]
14. Fine-needle aspiration of dermatofibrosarcoma protuberans metastasizing to hemithorax with superior vena cava compression: Case report and literature review.
Banach BS; Antic T; Bridge JA; Cipriani NA; Frye L; Krausz TN; Biernacka A
Diagn Cytopathol; 2019 Aug; 47(8):797-802. PubMed ID: 30919592
[TBL] [Abstract] [Full Text] [Related]
15. A novel case of an aggressive superficial spindle cell sarcoma in an adult resembling fibrosarcomatous dermatofibrosarcoma protuberans and harboring an EML4-NTRK3 fusion.
Olson N; Rouhi O; Zhang L; Angeles C; Bridge J; Lopez-Terrada D; Royce T; Linos K
J Cutan Pathol; 2018 Dec; 45(12):933-939. PubMed ID: 30175468
[TBL] [Abstract] [Full Text] [Related]
16. Congenital atrophic dermatofibrosarcoma protuberans detected by COL1A1-pdgfb rearrangement.
Makino M; Sasaoka S; Nakanishi G; Makino E; Fujimoto W
Diagn Pathol; 2016 Mar; 11():24. PubMed ID: 26932148
[TBL] [Abstract] [Full Text] [Related]
17. [Pigmented dermatofibrosarcoma protuberance: a clinicopathologic analysis of 7 cases].
Zhang J; Zhang RS; Wei X; Shi QL; Zhou XJ; Ma J
Zhonghua Bing Li Xue Za Zhi; 2013 Dec; 42(12):810-4. PubMed ID: 24507098
[TBL] [Abstract] [Full Text] [Related]
18. Fibroblast growth factor 2 orchestrates angiogenic networking in non-GIST STS patients.
Kilvaer TK; Valkov A; Sorbye SW; Smeland E; Bremnes RM; Busund LT; Donnem T
J Transl Med; 2011 Jul; 9():104. PubMed ID: 21733164
[TBL] [Abstract] [Full Text] [Related]
19. [Dermatofibrosarcoma protuberans].
Sanmartín O; Llombart B; López-Guerrero JA; Serra C; Requena C; Guillén C
Actas Dermosifiliogr; 2007 Mar; 98(2):77-87. PubMed ID: 17397592
[TBL] [Abstract] [Full Text] [Related]
20. The development and application of imatinib.
Jones RL; Judson IR
Expert Opin Drug Saf; 2005 Mar; 4(2):183-91. PubMed ID: 15794712
[TBL] [Abstract] [Full Text] [Related]
[Next]
